These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 26719752)

  • 1. Resolved lower limb muscle tone abnormalities in children with HIV encephalopathy receiving standard antiretroviral therapy.
    Mann TN; Donald KA; Walker KG; Langerak NG
    AIDS Res Ther; 2015; 12():43. PubMed ID: 26719752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spastic diplegia in children with HIV encephalopathy: first description of gait and physical status.
    Langerak NG; du Toit J; Burger M; Cotton MF; Springer PE; Laughton B
    Dev Med Child Neurol; 2014 Jul; 56(7):686-94. PubMed ID: 24182356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV Encephalopathy: pediatric case series description and insights from the clinic coalface.
    Donald KA; Walker KG; Kilborn T; Carrara H; Langerak NG; Eley B; Wilmshurst JM
    AIDS Res Ther; 2015; 12(1):2. PubMed ID: 25598835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia.
    Bolton-Moore C; Mubiana-Mbewe M; Cantrell RA; Chintu N; Stringer EM; Chi BH; Sinkala M; Kankasa C; Wilson CM; Wilfert CM; Mwango A; Levy J; Abrams EJ; Bulterys M; Stringer JS
    JAMA; 2007 Oct; 298(16):1888-99. PubMed ID: 17954540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Audiologic and vestibular findings in a sample of human immunodeficiency virus type-1-infected Mexican children under highly active antiretroviral therapy.
    Palacios GC; Montalvo MS; Fraire MI; Leon E; Alvarez MT; Solorzano F
    Int J Pediatr Otorhinolaryngol; 2008 Nov; 72(11):1671-81. PubMed ID: 18814921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A refined symptom-based approach to diagnose pulmonary tuberculosis in children.
    Marais BJ; Gie RP; Hesseling AC; Schaaf HS; Lombard C; Enarson DA; Beyers N
    Pediatrics; 2006 Nov; 118(5):e1350-9. PubMed ID: 17079536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurocognitive functioning in pediatric human immunodeficiency virus infection: effects of combined therapy.
    Shanbhag MC; Rutstein RM; Zaoutis T; Zhao H; Chao D; Radcliffe J
    Arch Pediatr Adolesc Med; 2005 Jul; 159(7):651-6. PubMed ID: 15996999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment Failure in HIV-Infected Children on Second-line Protease Inhibitor-Based Antiretroviral Therapy.
    Suaysod R; Ngo-Giang-Huong N; Salvadori N; Cressey TR; Kanjanavanit S; Techakunakorn P; Krikajornkitti S; Srirojana S; Laomanit L; Chalermpantmetagul S; Lallemant M; Le Cœur S; McIntosh K; Traisathit P; Jourdain G
    Clin Infect Dis; 2015 Jul; 61(1):95-101. PubMed ID: 25838288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and neuroimaging profile of HIV-1 encephalopathy in infancy and childhood in a sub-Saharan African country.
    G Mariam A; Assefa G
    Ethiop Med J; 2012 Oct; 50(4):337-47. PubMed ID: 23930479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
    Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
    Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment failure and mortality factors in patients receiving second-line HIV therapy in resource-limited countries.
    Pujades-Rodríguez M; Balkan S; Arnould L; Brinkhof MA; Calmy A;
    JAMA; 2010 Jul; 304(3):303-12. PubMed ID: 20639564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral treatment in pediatric HIV infection in the United States: from clinical trials to clinical practice.
    Brogly S; Williams P; Seage GR; Oleske JM; Van Dyke R; McIntosh K;
    JAMA; 2005 May; 293(18):2213-20. PubMed ID: 15886376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. AIDS Clinical Trials Group (ACTG) Study 152 Team.
    Englund JA; Baker CJ; Raskino C; McKinney RE; Petrie B; Fowler MG; Pearson D; Gershon A; McSherry GD; Abrams EJ; Schliozberg J; Sullivan JL
    N Engl J Med; 1997 Jun; 336(24):1704-12. PubMed ID: 9182213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and immunological outcomes of a national paediatric cohort receiving combination antiretroviral therapy in Uganda.
    Kiboneka A; Wangisi J; Nabiryo C; Tembe J; Kusemererwa S; Olupot-Olupot P; Joffres M; Anema A; Cooper CL; Montaner JS; Mills EJ
    AIDS; 2008 Nov; 22(18):2493-9. PubMed ID: 19005272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled corticosteroids in children with persistent asthma: effects on growth.
    Zhang L; Prietsch SO; Ducharme FM
    Evid Based Child Health; 2014 Dec; 9(4):829-930. PubMed ID: 25504972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outbreak of life-threatening thiamine deficiency in infants in Israel caused by a defective soy-based formula.
    Fattal-Valevski A; Kesler A; Sela BA; Nitzan-Kaluski D; Rotstein M; Mesterman R; Toledano-Alhadef H; Stolovitch C; Hoffmann C; Globus O; Eshel G
    Pediatrics; 2005 Feb; 115(2):e233-8. PubMed ID: 15687431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral therapy outcomes in resource-limited settings for HIV-infected children <5 years of age.
    Sauvageot D; Schaefer M; Olson D; Pujades-Rodriguez M; O'Brien DP
    Pediatrics; 2010 May; 125(5):e1039-47. PubMed ID: 20385636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe manifestations of extrapulmonary tuberculosis in HIV-infected children initiating antiretroviral therapy before 2 years of age.
    Walters E; Duvenhage J; Draper HR; Hesseling AC; Van Wyk SS; Cotton MF; Rabie H
    Arch Dis Child; 2014 Nov; 99(11):998-1003. PubMed ID: 24938535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.